Cyanopindolol

Cyanopindolol
Clinical data
ATC code	none;
Identifiers
	IUPAC name (RS)-4-[3-(tert-Butylamino)-2-hydroxypropoxy]-1H-indole-2-carbonitrile;
CAS Number	69906-85-0 ;
PubChem CID	155346;
IUPHAR/BPS	132;
ChemSpider	136847 ;
UNII	4K0SD5SNFS;
ChEMBL	ChEMBL378501 ;
PDB ligand	P32 (PDBe, RCSB PDB);
CompTox Dashboard (EPA)	DTXSID201027570 ;
Chemical and physical data
Formula	C16H21N3O2
Molar mass	287.363 g·mol−1
3D model (JSmol)	Interactive image;
Chirality	Racemic mixture
	SMILES N#CC1=CC2=C(OCC(CNC(C)(C)C)O)C=CC=C2N1;
	InChI InChI=1S/C16H21N3O2/c1-16(2,3)18-9-12(20)10-21-15-6-4-5-14-13(15)7-11(8-17)19-14/h4-7,12,18-20H,9-10H2,1-3H3 ; Key:QXIUMMLTJVHILT-UHFFFAOYSA-N ;
	(what is this?) (verify)

Cyanopindolol is a drug related to pindolol which acts as both a β₁ adrenoceptor antagonist and a 5-HT_1A receptor antagonist. Its radiolabelled derivative iodocyanopindolol has been widely used in mapping the distribution of beta adrenoreceptors in the body.^[1]

References

^ Hoyer D, Engel G (1983). "Binding of 125I-cyanopindolol to beta-1-adrenoceptors in a high and low affinity state". Journal of Receptor Research. 3 (1–2): 45–59. doi:10.3109/10799898309041922. PMID 6304308.

This antihypertensive-related article is a stub. You can help Wikipedia by expanding it.

v t e Beta blockers (C07)
β, non-selective	Alprenolol Bopindolol Bupranolol Carteolol Cloranolol Mepindolol Nadolol Oxprenolol Penbutolol Pindolol/Iodopindolol Propranolol^# Sotalol Tertatolol Timolol^#
β₁-selective	Acebutolol Atenolol Betaxolol Bevantolol Bisoprolol^# Celiprolol Epanolol Esmolol Landiolol Metoprolol Nebivolol Practolol Talinolol
β₂-selective	Butaxamine
α₁- + β-selective	Arotinolol Carvedilol Labetalol
^#WHO-EM ^‡Withdrawn from market Clinical trials: ^†Phase III ^§Never to phase III